IQVIA HOLDINGS INC (QTS.DE) Stock Fundamental Analysis
Europe - FRA:QTS - US46266C1053 - Common Stock
190.4 EUR
+1.85 (+0.98%)
QTS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 20 industry peers in the Life Sciences Tools & Services industry. QTS has an excellent profitability rating, but there are concerns on its financial health. QTS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QTS was profitable.
In the past year QTS had a positive cash flow from operations.
QTS had positive earnings in each of the past 5 years.
Each year in the past 5 years QTS had a positive operating cash flow.
1.2 Ratios
QTS has a Return On Assets of 4.32%. This is in the better half of the industry: QTS outperforms 65.00% of its industry peers.
With an excellent Return On Equity value of 21.41%, QTS belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
QTS has a Return On Invested Capital of 9.40%. This is in the better half of the industry: QTS outperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QTS is in line with the industry average of 7.43%.
The 3 year average ROIC (8.99%) for QTS is below the current ROIC(9.40%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.32% | ||
| ROE | 21.41% | ||
| ROIC | 9.4% |
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
1.3 Margins
QTS has a Profit Margin (7.88%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of QTS has grown nicely.
With a Operating Margin value of 14.41%, QTS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of QTS has grown nicely.
QTS has a Gross Margin of 34.25%. This is in the lower half of the industry: QTS underperforms 60.00% of its industry peers.
QTS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.41% | ||
| PM (TTM) | 7.88% | ||
| GM | 34.25% |
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QTS is destroying value.
The number of shares outstanding for QTS has been reduced compared to 1 year ago.
The number of shares outstanding for QTS has been reduced compared to 5 years ago.
Compared to 1 year ago, QTS has a worse debt to assets ratio.
2.2 Solvency
QTS has an Altman-Z score of 2.07. This is not the best score and indicates that QTS is in the grey zone with still only limited risk for bankruptcy at the moment.
QTS's Altman-Z score of 2.07 is on the low side compared to the rest of the industry. QTS is outperformed by 70.00% of its industry peers.
QTS has a debt to FCF ratio of 7.71. This is a slightly negative value and a sign of low solvency as QTS would need 7.71 years to pay back of all of its debts.
QTS has a Debt to FCF ratio of 7.71. This is comparable to the rest of the industry: QTS outperforms 50.00% of its industry peers.
QTS has a Debt/Equity ratio of 2.45. This is a high value indicating a heavy dependency on external financing.
QTS has a worse Debt to Equity ratio (2.45) than 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.45 | ||
| Debt/FCF | 7.71 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.93
WACC10.14%
2.3 Liquidity
QTS has a Current Ratio of 0.84. This is a bad value and indicates that QTS is not financially healthy enough and could expect problems in meeting its short term obligations.
QTS has a worse Current ratio (0.84) than 90.00% of its industry peers.
A Quick Ratio of 0.84 indicates that QTS may have some problems paying its short term obligations.
QTS has a worse Quick ratio (0.84) than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
QTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.13%, which is quite good.
Measured over the past years, QTS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.72% on average per year.
Looking at the last year, QTS shows a small growth in Revenue. The Revenue has grown by 3.60% in the last year.
QTS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.80% yearly.
EPS 1Y (TTM)9.13%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%6.44%
Revenue 1Y (TTM)3.6%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.32%
3.2 Future
The Earnings Per Share is expected to grow by 10.04% on average over the next years. This is quite good.
QTS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.48% yearly.
EPS Next Y7.58%
EPS Next 2Y8.03%
EPS Next 3Y8.68%
EPS Next 5Y10.04%
Revenue Next Year5.14%
Revenue Next 2Y5.01%
Revenue Next 3Y5.21%
Revenue Next 5Y5.48%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.27, the valuation of QTS can be described as rather expensive.
Based on the Price/Earnings ratio, QTS is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of QTS to the average of the S&P500 Index (26.89), we can say QTS is valued slightly cheaper.
QTS is valuated rather expensively with a Price/Forward Earnings ratio of 17.00.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QTS indicates a somewhat cheap valuation: QTS is cheaper than 70.00% of the companies listed in the same industry.
QTS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.27 | ||
| Fwd PE | 17 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QTS is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QTS indicates a somewhat cheap valuation: QTS is cheaper than 80.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.7 | ||
| EV/EBITDA | 14.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QTS does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of QTS may justify a higher PE ratio.
PEG (NY)2.54
PEG (5Y)1.64
EPS Next 2Y8.03%
EPS Next 3Y8.68%
5. Dividend
5.1 Amount
QTS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:QTS (10/24/2025, 7:00:00 PM)
190.4
+1.85 (+0.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.98%
Inst Owner ChangeN/A
Ins Owners0.86%
Ins Owner ChangeN/A
Market Cap32.37B
Revenue(TTM)15.70B
Net Income(TTM)1.24B
Analysts81.38
Price Target187.84 (-1.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1%
Min EPS beat(2)0.45%
Max EPS beat(2)1.56%
EPS beat(4)3
Avg EPS beat(4)0.36%
Min EPS beat(4)-0.62%
Max EPS beat(4)1.56%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)9
Avg EPS beat(12)0.84%
EPS beat(16)13
Avg EPS beat(16)1.1%
Revenue beat(2)2
Avg Revenue beat(2)0.45%
Min Revenue beat(2)0.4%
Max Revenue beat(2)0.5%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-0.14%
Revenue beat(12)4
Avg Revenue beat(12)-0.19%
Revenue beat(16)7
Avg Revenue beat(16)-0.12%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.02%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.27 | ||
| Fwd PE | 17 | ||
| P/S | 2.39 | ||
| P/FCF | 18.7 | ||
| P/OCF | 14.36 | ||
| P/B | 6.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.99 |
EPS(TTM)9.88
EY5.19%
EPS(NY)11.2
Fwd EY5.88%
FCF(TTM)10.18
FCFY5.35%
OCF(TTM)13.26
OCFY6.96%
SpS79.53
BVpS29.27
TBVpS-73.09
PEG (NY)2.54
PEG (5Y)1.64
Graham Number80.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.32% | ||
| ROE | 21.41% | ||
| ROCE | 10.75% | ||
| ROIC | 9.4% | ||
| ROICexc | 10.5% | ||
| ROICexgc | N/A | ||
| OM | 14.41% | ||
| PM (TTM) | 7.88% | ||
| GM | 34.25% | ||
| FCFM | 12.8% |
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
ROICexc(3y)9.76%
ROICexc(5y)7.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.28%
ROCE(5y)8.4%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y16.83%
ROICexc growth 5Y22.05%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
F-Score4
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.45 | ||
| Debt/FCF | 7.71 | ||
| Debt/EBITDA | 4.19 | ||
| Cap/Depr | 54.1% | ||
| Cap/Sales | 3.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 77.31% | ||
| Profit Quality | 162.49% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 2.07 |
F-Score4
WACC10.14%
ROIC/WACC0.93
Cap/Depr(3y)57.12%
Cap/Depr(5y)53.97%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.59%
Profit Quality(3y)136.6%
Profit Quality(5y)225.89%
High Growth Momentum
Growth
EPS 1Y (TTM)9.13%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%6.44%
EPS Next Y7.58%
EPS Next 2Y8.03%
EPS Next 3Y8.68%
EPS Next 5Y10.04%
Revenue 1Y (TTM)3.6%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.32%
Revenue Next Year5.14%
Revenue Next 2Y5.01%
Revenue Next 3Y5.21%
Revenue Next 5Y5.48%
EBIT growth 1Y7.86%
EBIT growth 3Y17.1%
EBIT growth 5Y21.64%
EBIT Next Year21.15%
EBIT Next 3Y11.05%
EBIT Next 5Y9.31%
FCF growth 1Y27.05%
FCF growth 3Y-2.8%
FCF growth 5Y20.42%
OCF growth 1Y16.73%
OCF growth 3Y-2.63%
OCF growth 5Y13.9%
IQVIA HOLDINGS INC / QTS.DE FAQ
What is the ChartMill fundamental rating of IQVIA HOLDINGS INC (QTS.DE) stock?
ChartMill assigns a fundamental rating of 4 / 10 to QTS.DE.
Can you provide the valuation status for IQVIA HOLDINGS INC?
ChartMill assigns a valuation rating of 5 / 10 to IQVIA HOLDINGS INC (QTS.DE). This can be considered as Fairly Valued.
What is the profitability of QTS stock?
IQVIA HOLDINGS INC (QTS.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for QTS stock?
The Price/Earnings (PE) ratio for IQVIA HOLDINGS INC (QTS.DE) is 19.27 and the Price/Book (PB) ratio is 6.5.
What is the expected EPS growth for IQVIA HOLDINGS INC (QTS.DE) stock?
The Earnings per Share (EPS) of IQVIA HOLDINGS INC (QTS.DE) is expected to grow by 7.58% in the next year.